New drug to inhibit bone loss called Skelid (SKEL-id, tiludronate)
April 1997
                                    
                                    Sanofi is launching a new drug to inhibit bone   loss called Skelid (SKEL-id, tiludronate). It...
                                Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
 - Quick, practical reference charts and tools
 - Comprehensive CE library to meet license renewal and state requirements
 - Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
 - Plus much more!
 
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote